Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the RSV fusion protein

Details for Australian Patent Application No. 2005224159 (hide)

Owner Arrow Therapeutics Limited

Inventors Alber, Dagmar; Dowdell, Verity; Carter, Malcoml; Powell, Kenneth; Henderson, Elisa; Kelsey, Richard

Agent Davies Collison Cave

Pub. Number AU-B-2005224159

PCT Pub. Number WO2005/089771

Priority 0406279.0 19.03.04 GB

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 21 May 2009

International Classifications

A61K 31/5513 (2006.01)

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/089771 Priority application(s): WO2005/089771

21 May 2009 Application Accepted

  Published as AU-B-2005224159

17 September 2009 Standard Patent Sealed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224160-The treatment of inflammatory disorders and pain using betaaminoalcohols

2005224158-Benzodiazepines for treating or preventing or preventing RSV infection